JDEP:EURONEXT AMSTERDAMJDE Peet's NV Analysis
Data as of 2026-06-04 - not real-time
$17.05
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
JDE Peet's shares are trading at $17.05, which sits below the 20‑day (≈$17.28) and 50‑day (≈$17.94) simple moving averages and is also under the 200‑day SMA (≈$18.20), signaling a bearish price alignment despite a modestly bullish MACD histogram and a MACD line that has just crossed above its signal line. The RSI hovers around 42, indicating neutral momentum, while volume has been trending upward, suggesting that market participants are actively watching the stock. The price is perched near the calculated support level of $16.81, with resistance around $18.61, and the 30‑day volatility exceeds 30%, reflecting a relatively choppy trading environment; however, the beta of just 0.18 points to low systematic risk.
On the fundamentals side, JDE Peet's delivers solid revenue growth of roughly 5% and maintains healthy gross margins near 31%, but its balance sheet is weighted heavily toward debt (debt‑to‑equity ≈50) and a modest free cash flow of $0.62 bn. The dividend yield of 2.5% with a payout ratio under 50% appears sustainable, yet the discounted cash‑flow fair value of about $6.70 is dramatically lower than the market price, flagging the stock as potentially overvalued. Recent material news – the completion of the Keurig Dr Pepper acquisition and a consent solicitation for outstanding Euro notes – adds integration and refinancing considerations that could influence future cash flows and risk profile.
On the fundamentals side, JDE Peet's delivers solid revenue growth of roughly 5% and maintains healthy gross margins near 31%, but its balance sheet is weighted heavily toward debt (debt‑to‑equity ≈50) and a modest free cash flow of $0.62 bn. The dividend yield of 2.5% with a payout ratio under 50% appears sustainable, yet the discounted cash‑flow fair value of about $6.70 is dramatically lower than the market price, flagging the stock as potentially overvalued. Recent material news – the completion of the Keurig Dr Pepper acquisition and a consent solicitation for outstanding Euro notes – adds integration and refinancing considerations that could influence future cash flows and risk profile.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price near technical support with bearish SMA alignment
- Increasing volume indicating active market participation
- Neutral RSI and slight bullish MACD hint at limited upside
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Integration of Keurig Dr Pepper could unlock synergies
- Sustainable dividend yield supports shareholder returns
- High leverage may constrain capital allocation
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- Market price far exceeds DCF fair value
- Elevated debt levels raise solvency concerns
- Limited growth prospects in a mature packaged‑foods sector
Key Metrics & Analysis
Financial Health
Revenue Growth5.40%
Profit Margin8.02%
P/E Ratio18.1
ROE7.18%
ROA2.02%
Debt/Equity49.62
P/B Ratio1.3
Op. Cash Flow$1.4B
Free Cash Flow$619.2M
Technical Analysis
TrendBearish
RSI42.5
Support$16.81
Resistance$18.61
MA 20$17.28
MA 50$17.94
MA 200$18.20
MACDBullish
VolumeIncreasing
Fear & Greed Index92.75
Valuation
Fair Value$6.69
GradeOvervalued
TypeBlend
Dividend Yield2.51%
Risk Assessment
Beta0.19
Volatility30.18%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.